4000 IU Erythropoietin Injection IP

Name: 4000 IU Erythropoietin Injection IP
Brand: NEETCO BIOPHARMA
Price: 150 INR
Availability: InStock

Price 150 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

4000 IU Erythropoietin Injection IP Specification

Appearance
Clear, colorless to pale yellow solution

Molecular Formula
C815H1317N233O241S5

Physical Form
Injection (liquid in prefilled syringe or vial)

CAS No
113427-24-0

Suitable For
Adults and pediatric patients with anemia due to chronic kidney disease, chemotherapy, or other causes

Solubility
Completely soluble in water

Purity
>98% (recombinant protein)

HS Code
3002

Dosage Guidelines
As directed by physician; typically injected subcutaneously or intravenously

Assay
4000 IU per syringe/vial

Pacakaging (Quantity Per Box)
1 prefilled syringe/vial per box

Melting Point
Not applicable (protein solution)

Type
Biological Erythropoiesis-Stimulating Agent

Ingredients
Recombinant human erythropoietin alpha, buffer, stabilizers, water for injection

Feature
Stimulates red blood cell production; recombinant human erythropoietin

Shelf Life
24 months from date of manufacture

Storage Instructions
Store at 2C8C; do not freeze; protect from light

Adverse Effects
Hypertension, fever, headache, joint pains, injection site reactions

Therapeutic Indication
Treatment of anemia, especially related to chronic renal failure and cancer chemotherapy

Brand Name
As per availability (refer to packaging)

Caution
Monitor hemoglobin levels regularly; risk of serious cardiovascular events if dosage is not properly adjusted

Route of Administration
Subcutaneous or intravenous injection

Prescription Category
Prescription only (Rx)

Contraindications
Known hypersensitivity to erythropoietin or excipients

Strength
4000 IU/0.4ml (standard pack)

Use in Pregnancy
Use only if clearly needed and prescribed by a physician

About 4000 IU Erythropoietin Injection IP

Find the latest in world-class anemia management with the 4000 IU Erythropoietin Injection IP. Radiant efficacy meets towering standards, this prescription-only biological agent stimulates robust red blood cell production-essential for adults and pediatric patients battling anemia due to chronic kidney disease or cancer chemotherapy. Available in a precise 4000 IU/0.4ml standard pack, this recombinant protein offers >98% purity. Administration is subcutaneous or intravenous, with markdown packaging including a prefilled syringe or vial per box. Always refer to the brand indicated on the packaging.

Versatile Usage and Applications

4000 IU Erythropoietin Injection IP is designed for both subcutaneous and intravenous injection, using advanced recombinant technology. This medical solution is suitable for application in hospitals, specialty clinics, and home healthcare settings under professional supervision. It is used for the treatment of anemia, particularly when associated with chronic kidney disease and cancer chemotherapy, offering hope and improved health outcomes for adults and pediatric patients.

Sample Policy and Fast Delivery

Sample requests for 4000 IU Erythropoietin Injection IP are honored under strict prescription guidelines. Payment terms are flexible, supporting timely transactions for buyers. With a supply ability that aligns with market demand, goods transport incorporates express shipping for rapid delivery, ensuring product integrity and timely access to life-saving medication, whether for bulk distribution or immediate need.

FAQ's of 4000 IU Erythropoietin Injection IP:

Q: How is 4000 IU Erythropoietin Injection IP administered?

A: This injection is administered either subcutaneously or intravenously as directed by a physician, depending on the patient's needs and therapeutic indication.

Q: What are the main benefits of using this erythropoietin injection?

A: It stimulates the production of red blood cells, effectively treating anemia related to chronic renal failure and cancer chemotherapy, improving energy and quality of life for patients.

Q: Where should this medication be stored before use?

A: Store the injection at 2C-8C, protected from light, and ensure it is not frozen to preserve its efficacy.

Q: When should hemoglobin levels be monitored during treatment?

A: Hemoglobin levels should be regularly monitored throughout the treatment process to avoid complications and adjust dosage as necessary.

Q: What are the possible adverse effects associated with the use of this product?

A: Adverse effects can include hypertension, fever, headache, joint pains, and injection site reactions. It's crucial to report any unusual symptoms to your healthcare provider.

Q: Who is eligible to use the 4000 IU Erythropoietin Injection IP?

A: It is suitable for adults and children with anemia caused by chronic kidney disease, cancer chemotherapy, or other related conditions, as prescribed by a physician.

Tell us about your requirement